/biz/ - Business & Finance

>>16556187
Biotech has run pretty hard. One of the biggest sector runs this year.

I wouldn’t be shocked if the ETFs that have been lifting up the bad with the good start to exert downward pressure on the whole sector, particularly the ones who have yet to live up to their promise. If we’re lucky, this may give us buying opportunities in companies like regeneron, Amgen, biomarin.

The AMRN/Tbaby poster wasn’t being called a retard because of amarin, it’s because of shit like pic related.

>>16556235
Have you done any research into them or just hoping on the fomo trade to dump it on the greater fool? I think we may be in for a bit of a lull until we get closer to the JPM conference. Crispr isn’t one that stood out to me from the credit suisse biotech report. It looks like they were right about sarrepta, we’ll see if biomarin or uniqure pan out.

Remember that you can also play the sector through ETFs. If we’d all bought the IBB before ASH, instead of gambling on trades that mostly didn’t pan out, we’d have done pretty damn well.

>>16502565
“Holy buyout” guy has made it clear that:
1. Adcom results guarantee FDA approval
2. He’s a total retard

Buy the hype and sell the news is almost certainly how this will go. It will rally into the fda meeting, and what happens after that is completely unknown. What happens before then is also unknown.

See pic if you want a good idea of how little homework he does.

>>16482181
>listening to this retard
>ever